Vertex Pharmaceuticals Inc (VRTX) Com Stk

Sell:$454.18Buy:$454.25Price decreased$3.85 (0.84%)

NASDAQ:Price decreased2.01%
Market closed |
Prices delayed by at least 15 minutes
Sell:$454.18
Buy:$454.25
Change:Price decreased$3.85 (0.84%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$454.18
Buy:$454.25
Change:Price decreased$3.85 (0.84%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
13 March 2026
Carmen BozicOther Level A
Sell
Regular sell transaction (market)
2,329$481.79$1,122,088.9135,405
11 March 2026
Duncan J McKechnieChief Level Officer
Sell
Regular sell transaction (market)
2,633$498.42$1,312,339.8612,489
4 March 2026
Duncan J McKechnieChief Level Officer
Sell
Regular sell transaction (market)
2,437$475.30$1,158,306.1015,122
2 March 2026
Joy LiuChief Legal/Compliance Officer
Sell
Regular sell transaction (market)
892$495.96$442,396.3222,811
27 February 2026
Reshma KewalramaniPresident/CEO
Sell
Regular sell transaction (market)
400$479.75$191,900.00137,878
27 February 2026
Reshma KewalramaniPresident/CEO
Sell
Regular sell transaction (market)
120$481.50$57,780.00137,758
27 February 2026
Reshma KewalramaniPresident/CEO
Sell
Regular sell transaction (market)
240$482.84$115,881.60137,518
27 February 2026
Reshma KewalramaniPresident/CEO
Sell
Regular sell transaction (market)
2,510$487.13$1,222,696.30135,008
27 February 2026
Reshma KewalramaniPresident/CEO
Sell
Regular sell transaction (market)
3,278$488.27$1,600,549.06131,730
27 February 2026
Reshma KewalramaniPresident/CEO
Sell
Regular sell transaction (market)
460$489.32$225,087.20131,270

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 July 2025
Stuart A ArbuckleCOO
Sell
Tax related
37,243$450.23$16,767,915.8963,368
14 November 2025
Jeffrey M LeidenExecutive Chairman
Sell
Option/Award related
32,234$440.30$14,192,630.2045,396
14 November 2025
Jeffrey M LeidenExecutive Chairman
Sell
Option/Award related
21,330$441.35$9,413,995.5024,066
19 February 2026
Amit K. SachdevExecutive Vice President
Sell
Option/Award related
19,662$468.57$9,213,023.3482,124
13 November 2025
Jeffrey M LeidenExecutive Chairman
Sell
Option/Award related
18,528$440.22$8,156,396.1625,186

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.